• No results found

Crossing the Doughnut Hole: The Effects of the Medicare Drug Coverage Gap for Patients who Require High-cost Medications

N/A
N/A
Protected

Academic year: 2021

Share "Crossing the Doughnut Hole: The Effects of the Medicare Drug Coverage Gap for Patients who Require High-cost Medications"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

(1)

Crossing the Doughnut Hole:

The Effects of the Medicare Drug Coverage Gap

for Patients who Require High-cost Medications

AcademyHealth Annual Research Meeting

June 29, 2009

Dominick Esposito

1

, Margaret Colby

1

, Daniel Ball

2

,

Susan Garavaglia

3

, Eric Meadows

2

, Martin Marciniak

2 1Mathematica Policy Research, Inc.

2 Eli Lilly and Company 3 Medco Health Solutions, Inc.

(2)

Research Objectives

Estimate the proportion of beneficiaries that

reach the Part D doughnut hole or catastrophic

coverage in 2007

Calculate the time to reach each coverage

phase from each person’s first fill

Identify the factors affecting the likelihood of

reaching each coverage phase

(3)

2007 pharmacy claims from Medco Health Solutions, Inc.

Medicare Part D beneficiaries with cancer, osteoporosis, or rheumatoid arthritis

Prescription drug plan (PDP) or retiree drug subsidy (RDS)PDP—varying exposure to doughnut hole

Standard PDPEnhanced PDP

Medicare Advantage PDPRDS—no doughnut hole

Randomly selected a matched comparison group with other

chronic conditions

Plan type (PDP/RDS), age, gender, geography, chronic disease score, and low-income subsidy (LIS) eligibility

(4)

Sample Characteristics: Plan Enrollment

Cancer Osteoporosis

Rheumatoid Arthritis

Other Chronic Conditions

Sample Size 31,979 325,091 5,566 362,412

Drug Plan Type

Standard PDP 4.1 3.5 5.2 3.8

Enhanced PDP 5.4 5.4 5.2 5.1

Medicare Advantage PDP 28.6 27.2 22.3 27.6

Retiree drug subsidy 62.0 63.8 67.3 63.6

Doughnut Hole Exposure

No doughnut hole 74.1 75.3 82.8 74.6

Partial doughnut hole 6.8 5.9 4.0 6.3

Standard doughnut hole 19.0 18.8 13.3 19.2

Among PDP enrollees, about 50% had the standard doughnut hole. Figures in table are percentages.

(5)

Sample Characteristics: Demographics

Cancer Osteoporosis

Rheumatoid Arthritis

Other Chronic Conditions

Sample Size 31,979 325,091 5,566 362,412

LIS Eligible 7.2 6.4 10.2 6.5

Female 92.1 92.1 60.2 91.6

5 or More Chronic Conditions 42.2 37.5 44.8 37.2

Age

Under 65 4.0 2.6 20.4 3.0

65-74 44.1 37.5 52.1 38.3

75 and over 51.9 59.9 27.4 58.7

(6)

Study Design: Methods

Equivalent drug spending thresholds were calculated for

plans without a standard Part D doughnut hole.

Survival analysis

Time until spending reached $2,400 (doughnut hole) or $5,451 (catastrophic coverage)

Logistic regression analysis

Likelihood of reaching each spending threshold

Key explanatory variables included: plan type, doughnut hole exposure, disease type, demographic characteristics

(7)
(8)

Results: Time to Reach Spending Thresholds

Cancer Osteoporosis Rheumatoid Arthritis

Other Chronic Conditions From First Fill, Average Days to

Reach:

$2,400 (Doughnut hole) 160 196 85 195

$5,451 (Catastrophic coverage) 206 245 133 254

From Doughnut Hole, Average Days

to Reach Catastrophic Coverage 107 138 73 144

Beneficiaries Reached the Doughnut Hole Spending Equivalent ~ 3 to 6.5 Months After Their First Fill

In a standard PDP design, out-of-pocket cost would reach $800 by the time a beneficiary reaches the doughnut hole, and $3,850 by catastrophic coverage.

(9)

Results: Time Spent in the Doughnut Hole

0.0 0.2 0.4 0.6 0.8 1.0

0 30 60 90 120 150 180 210 240 270 300 330 360

E st im at ed pr obabi lit y of sp endi ng not reach ing $5, 451 ( ca tast rophi c co ve rage)

Patients Who Reach Catastrophic Coverage Spending Equivalent Spent 1 to 7 Months in the Doughnut Hole

(Estimated Survival Function)

Cancer Osteoporosis RA

(10)

Results: Odds of Reaching Spending Thresholds

$2,400 (Doughnut Hole)

$5,451

(Catastrophic Coverage) Primary Condition

Cancer 12.12** 4.08**

Osteoporosis 2.12** 1.35**

Rheumatoid arthritis 19.81** 22.40**

Other chronic conditions (reference) --

--Drug Coverage Type

Enhanced PDP 1.00 1.21**

Medicare Advantage PDP 0.72** 0.94*

Retiree Drug Subsidy 1.02 1.01

Standard PDP (reference) --

--Benefit Plan Design

Partial doughnut hole 0.96 0.54**

Doughnut hole 0.91** 0.62**

No doughnut hole (reference) --

(11)

Conclusions and Policy Implications

Beneficiaries with cancer, rheumatoid arthritis, or

osteoporosis may face expensive drug regimens.

Most in this sample had spending that reached the doughnut hole.

Differences by plan type and benefit design raise further questions.

Despite high out-of-pocket costs, many spend through the

doughnut hole to reach catastrophic coverage.

By the time beneficiaries reach catastrophic coverage, they

have incurred $3,850 in out-of-pocket costs in the standard PDP.Continued 5% cost sharing in catastrophic coverage.

For beneficiaries with these conditions, available

References

Related documents

By the end of 2015, a total of 5856 embryo transfer (ET) cycles carried out and resulted in clinical pregnancies in Reproductive Medicine Center of the Affiliated Nanjing Maternity

The investigation was performed on five tissue phantoms with different stiffness using a research platform capable of inducing and tracking shear waves and a clinical cardiac

C alcium glucarate as a chemopreventative agent in breast cancer Israel Journal of Medical

te voorkomen. Niet omdat de rechter van mening is dat een ruime uitleg van het grondrecht gewenst zou zijn. De 'margin of appreciation' die het EHRM aan de

The RX6ACI Receive Antenna Switch Control System provides users the ability to select one of six receive antennas with the click of a mouse button while

TECHNICAL DATA Count input – Phase discriminator with single evaluation, impulse resolution in mm, cm, dm (Standard) Prescaler (only-P version) 0.0005…99.9999 Length